Showing results (51-60 of 2,397) with videos related to
Sort By:
Pageof 240
Translational Lung Cancer Research|December 3, 2015
Interlobar fixation using TachoSil(®): a novel techniqueAlfonso Fiorelli, Roberto Scaramuzzi, Saveria Costanzo, et al.Translational Lung Cancer Research|December 3, 2015
What do we know about ground-glass opacity nodules in the lung?Choon-Taek LeeTranslational Lung Cancer Research|September 15, 2017
Circulating tumor cell interactions with macrophages: implications for biology and treatmentGerhard Hamilton, Barbara RathTranslational Lung Cancer Research|September 15, 2017
Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer-ready for prime-time?Emma Pailler, Vincent Faugeroux, Marianne Oulhen, et al.Translational Lung Cancer Research|September 27, 2019
Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based studyXuan-Qi Zheng, Jin-Feng Huang, Jia-Liang Lin, et al.Translational Lung Cancer Research|September 27, 2019
Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR study)Mariano Provencio, Enric Carcereny, Delvys Rodríguez-Abreu, et al.Translational Lung Cancer Research|September 27, 2019
Influence and mechanism of lung cavitation development on antiangiogenic therapyMan Jiang, Chuantao Zhang, Dong Liu, et al.Translational Lung Cancer Research|September 27, 2019
Sensitive molecular testing methods can demonstrate NSCLC driver mutations in malignant pleural effusion despite non-malignant cytologyDaniel P Steinfort, Sevastjan Kranz, Anthony Dowers, et al.Translational Lung Cancer Research|February 3, 2017
Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the futureClaudia Proto, Martina Imbimbo, Rosaria Gallucci, et al.Translational Lung Cancer Research|February 3, 2017
Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistanceRoberta Minari, Paola Bordi, Marcello TiseoPageof 240